BMS bags UK advanced melanoma win for Opdualag

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

Dec 28, 2023 - 18:00

BMS bags UK advanced melanoma win for Opdualag

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

Read the original article

Tags:

Previous Article

STAT+: 3 medtech trends to watch in 2024

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

AI startup Leucine raises $7m for drug manufacturing digital twin platform

AI startup Leucine raises $7m for drug manufacturing di...

Oct 17, 2023

AB Science announces Canadian patent for masitinib to treat ALS

AB Science announces Canadian patent for masitinib to t...

Jun 3, 2023

Risk adjusted net present value: What is the current va...

Jan 11, 2024